Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, 10 (6)

The Role of Magnesium in Neurological Disorders

Affiliations
Review

The Role of Magnesium in Neurological Disorders

Anna E Kirkland et al. Nutrients.

Abstract

Magnesium is well known for its diverse actions within the human body. From a neurological standpoint, magnesium plays an essential role in nerve transmission and neuromuscular conduction. It also functions in a protective role against excessive excitation that can lead to neuronal cell death (excitotoxicity), and has been implicated in multiple neurological disorders. Due to these important functions within the nervous system, magnesium is a mineral of intense interest for the potential prevention and treatment of neurological disorders. Current literature is reviewed for migraine, chronic pain, epilepsy, Alzheimer’s, Parkinson’s, and stroke, as well as the commonly comorbid conditions of anxiety and depression. Previous reviews and meta-analyses are used to set the scene for magnesium research across neurological conditions, while current research is reviewed in greater detail to update the literature and demonstrate the progress (or lack thereof) in the field. There is strong data to suggest a role for magnesium in migraine and depression, and emerging data to suggest a protective effect of magnesium for chronic pain, anxiety, and stroke. More research is needed on magnesium as an adjunct treatment in epilepsy, and to further clarify its role in Alzheimer’s and Parkinson’s. Overall, the mechanistic attributes of magnesium in neurological diseases connote the macromineral as a potential target for neurological disease prevention and treatment.

Keywords: Alzheimer’s; Parkinson’s; chronic pain; epilepsy; excitotoxicity; glutamate; magnesium; migraine; stroke.

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Glutamatergic N-methyl-d-aspartate receptor with magnesium block of calcium channel. Reprinted from [8] with permission from Elsevier.
Figure 2
Figure 2
Flow chart of magnesium in neurological disorders literature. New papers refer to published research not included in previously-published reviews and meta-analyses. AD = Alzheimer’s Disease; PD = Parkinson’s Disease.

Similar articles

  • The Effect of Magnesium Deficiency on Neurological Disorders: A Narrative Review Article
    W Xue et al. Iran J Public Health 48 (3), 379-387. PMID 31223564. - Review
    Magnesium has effects on neurological disorders, such as its utility in cerebral vasospasm, Alzheimer's disease, Parkinson's disease, stroke and migraine. So here we make …
  • [New Drugs in Neurology]
    HP Mattle. Praxis (Bern 1994) 88 (18), 827-34. PMID 10409881. - Review
    This article reviews new drugs and recent knowledge or indications for old drugs for the treatment of neurological disorders. Drugs for disorders such as migraine, epilep …
  • Magnesium in Prevention and Therapy
    U Gröber et al. Nutrients 7 (9), 8199-226. PMID 26404370. - Review
    Magnesium is the fourth most abundant mineral in the body. It has been recognized as a cofactor for more than 300 enzymatic reactions, where it is crucial for adenosine t …
  • Magnesium in the CNS: Recent Advances and Developments
    R Vink. Magnes Res 29 (3), 95-101. PMID 27829572. - Review
    A potential neuroprotective role for magnesium in neurological disease has been appreciated for almost three decades, yet translation to the clinical arena has proven elu …
  • Excitotoxicity: Bridge to Various Triggers in Neurodegenerative Disorders
    A Mehta et al. Eur J Pharmacol 698 (1-3), 6-18. PMID 23123057. - Review
    Glutamate is one of the most prominent neurotransmitter in the body, present in over 50% of nervous tissue and plays an important role in neuronal excitation. This neuron …
See all similar articles

Cited by 6 PubMed Central articles

See all "Cited by" articles

References

    1. Grober U., Schmidt J., Kisters K. Magnesium in prevention and therapy. Nutrients. 2015;7:8199–8226. doi: 10.3390/nu7095388. - DOI - PMC - PubMed
    1. Vink R., Nechifor M. Magnesium in the Central Nervous System. University of Adelaide Press; Adelaide, Australia: 2011. p. 342.
    1. Stroebel D., Casado M., Paoletti P. Triheteromeric nmda receptors: From structure to synaptic physiology. Curr. Opin. Physiol. 2018;2:1–12. doi: 10.1016/j.cophys.2017.12.004. - DOI - PMC - PubMed
    1. Castilho R.F., Ward M.W., Nicholls D.G. Oxidative stress, mitochondrial function, and acute glutamate excitotoxicity in cultured cerebellar granule cells. J. Neurochem. 1999;72:1394–1401. doi: 10.1046/j.1471-4159.1999.721394.x. - DOI - PubMed
    1. Olloquequi J., Cornejo-Cordova E., Verdaguer E., Soriano F.X., Binvignat O., Auladell C., Camins A. Excitotoxicity in the pathogenesis of neurological and psychiatric disorders: Therapeutic implications. J. Psychopharmacol. 2018;32:265–275. doi: 10.1177/0269881118754680. - DOI - PubMed

MeSH terms

Feedback